Status:
COMPLETED
Prediabetes and Type 2 Diabetes in Aging
Lead Sponsor:
Uşak University
Conditions:
Type 2 Diabetes Mellitus (T2DM)
Cognitive Function
Eligibility:
All Genders
60+ years
Brief Summary
This case-control study will evaluate the effects of geriatric individuals on cognitive status, physical function and fatigue. Our study aims to compare the effects of geriatric individuals with predi...
Detailed Description
Type 2 Diabetes Mellitus develops due to insulin resistance and/or decreased insulin secretion and is particularly common in the elderly population. With the aging process, metabolic changes and incre...
Eligibility Criteria
Inclusion
- for people without diabetes (healthy), those with Hemoglobin A1c Levels (HbA1c) normal range between 4% and 5.6%,
- those with HbA1c level between 5.7% and 6.4%, those with prediabetes (Impaired Glucose Tolerance),
- those with 6.5% -7.5% level and
- those with HbA1c level above 7.5
- criteria are being 60 years of age and older,
Exclusion
- those who have major depression,
- uncontrolled thyroid disease,
- those with vitamin B12, folic acid deficiency and anemia,
- those with uncontrolled hypertension,
- those with nephropathy and retrophy,
- those with any neuropsychological disorder, a history of alcohol, substance or drug addiction,
- those using any neurological or psychological medication (anticonvulsant drugs, antidepressants, anxiolytics, etc.),
- those with Alzheimer's and Parkinson's disease,
- those with cancer,
- those with lung disease
Key Trial Info
Start Date :
April 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2025
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06953609
Start Date
April 15 2025
End Date
August 15 2025
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uşak Education and Research Hospital
Uşak, Uşak, Turkey (Türkiye), 64200